Cargando…

Impact renaming non-alcoholic fatty liver disease to metabolic associated fatty liver disease in prevalence, characteristics and risk factors

BACKGROUND: Recently, a group of hepatologists proposed to rename non-alcoholic fatty liver disease (NAFLD) as metabolic associated fatty liver disease (MAFLD) with modified diagnostic criteria. It is important to note, however, that there are some differences between the diagnostic criteria used fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Xin-Juan, Yin, Man, Zhou, Bing-Qian, Tan, Xin-Yun, Xia, Yuan-Qin, Qin, Chun-Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494565/ https://www.ncbi.nlm.nih.gov/pubmed/37701916 http://dx.doi.org/10.4254/wjh.v15.i8.985

Ejemplares similares

Problems and Challenges Associated with Renaming Non-alcoholic Fatty Liver Disease to Metabolic Associated Fatty Liver Disease
por: Zeng, Minghui, et al.
Publicado: (2023)

Prevalence of sarcopenia using different methods in patients with non-alcoholic fatty liver disease
por: Almeida, Naiade Silveira, et al.
Publicado: (2022)

Neglected features of lifestyle: Their relevance in non-alcoholic fatty liver disease
por: Trovato, Francesca M, et al.
Publicado: (2016)

Skeletal muscle loss is associated with diabetes in middle-aged and older Chinese men without non-alcoholic fatty liver disease
por: Chen, Ling-Yan, et al.
Publicado: (2021)

Red blood cell distribution width derivatives in alcohol-related liver cirrhosis and metabolic-associated fatty liver disease
por: Michalak, Agata, et al.
Publicado: (2022)

Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population
por: Lind, Lars, et al.
Publicado: (2020)

HOMA-IR is an effective biomarker of non-alcoholic fatty liver disease in non-diabetic population
por: Zeng, Pei, et al.
Publicado: (2023)

Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease
por: Biolato, Marco, et al.
Publicado: (2019)

Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease
por: Hernández-Conde, Marta, et al.
Publicado: (2020)

Characterization of patients with both alcoholic and nonalcoholic fatty liver disease in a large United States cohort
por: Khoudari, George, et al.
Publicado: (2019)

Impact of sodium glucose cotransporter-2 inhibitors on liver steatosis/fibrosis/inflammation and redox balance in non-alcoholic fatty liver disease
por: Bellanti, Francesco, et al.
Publicado: (2022)

Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndrome
por: Shengir, Mohamed, et al.
Publicado: (2020)

Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients
por: Zelber-Sagi, Shira, et al.
Publicado: (2017)

Pediatric non-alcoholic fatty liver disease and kidney function: Effect of HSD17B13 variant
por: Di Sessa, Anna, et al.
Publicado: (2020)

Prevalence of nonalcoholic fatty liver disease and its association with age in patients with type 2 diabetes mellitus
por: Yamane, Ryosuke, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases
por: Kablawi, Dana, et al.
Publicado: (2023)

Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
por: Yan, Hong-Mei, et al.
Publicado: (2015)

Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China
por: Shen, Zi-Xuan, et al.
Publicado: (2022)

Association between endotoxemia and histological features of nonalcoholic fatty liver disease
por: Kitabatake, Hiroyuki, et al.
Publicado: (2017)

Interrelationship between physical activity and depression in nonalcoholic fatty liver disease
por: Weinstein, Ali A, et al.
Publicado: (2022)

Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease
por: Gelli, Chiara, et al.
Publicado: (2017)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease()
por: Khambu, Bilon, et al.
Publicado: (2018)

Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease
por: Tan, Panli, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history
por: Magrì, Salvatore, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease Is a Risk Factor for Thiopurine Hepatotoxicity in Crohn’s Disease
por: George, Alvin T, et al.
Publicado: (2023)

Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
por: Valenzuela-Vallejo, Laura, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis
por: Damiani, Giovanni, et al.
Publicado: (2019)

Alcohol and Metabolic-associated Fatty Liver Disease
por: Sun, Fu-Rong, et al.
Publicado: (2021)

Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study
por: Pereira, Evelyn Nunes Goulart da Silva, et al.
Publicado: (2021)

Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease
por: Dai, Yi-Ning, et al.
Publicado: (2022)

Impact of non-alcoholic fatty liver disease and smoking on colorectal polyps
por: Chen, Qin-Fen, et al.
Publicado: (2017)

Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease
por: Salgado Alvarez, Giovanni Alejandro, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease
por: Sattar, Naveed, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease
por: Neuschwander-Tetri, Brent A.
Publicado: (2017)

Screening strategy for non-alcoholic fatty liver disease
por: Zhang, Saisai, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease and liver secretome
por: Khan, Muhammad Sohaib, et al.
Publicado: (2022)

Nuts and Non-Alcoholic Fatty Liver Disease: Are Nuts Safe for Patients with Fatty Liver Disease?
por: Plaz Torres, Maria Corina, et al.
Publicado: (2020)

Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?
por: Devi, Jalpa, et al.
Publicado: (2022)

Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease
por: Wu, Dongqing, et al.
Publicado: (2021)

Is Fatty Liver Associated With Depression? A Meta-Analysis and Systematic Review on the Prevalence, Risk Factors, and Outcomes of Depression and Non-alcoholic Fatty Liver Disease
por: Xiao, Jieling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_28p46teriqivp1lrg0uvfqnjuo